Biogen, Inc. (NQ: BIIB )

383.52 USD -7.79 (-1.99%)

Streaming Delayed Price Updated: 4:00 PM EDT, Jun 17, 2021 Add to My Watchlist

Price and Volume

Volume	1,832,967
Open	391.31
Bid (Size)	382.01 (1)
Ask (Size)	383.55 (2)
Prev. Close	391.31
Today's Range	380.17 - 396.89
52wk Range	223.25 - 468.35
Shares Outstanding	150,554,750
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Best Stocks Moving Today? 4 Biotech Names To Watch

June 17, 2021

Biogen Announces First Patient Dosed in Phase 3 Systemic Lupus Erythematosus Study

June 17, 2021

Performance

YTD	+57.86%	+57.86%
1 Month	+36.48%	+36.48%
3 Month	+46.23%	+46.23%
6 Month	+53.26%	+53.26%
1 Year	+36.26%	+36.26%

More News

Biogen Announces Topline Results From Phase 2 Study of Gosuranemab, an Anti-Tau Antibody, for Alzheimer’s Disease

June 16, 2021

4 Undervalued Biotech Stocks That Belong On Every Investor’s Buy List

June 17, 2021

AMD And Nvidia Lead The Nasdaq Higher Thursday

June 17, 2021

Biogen Commences Dosing In Late-Stage Systemic Lupus Erythematosus Study With BIIB059

June 17, 2021

Thinking about trading options or stock in Prothena Corp, CureVac, Centene Corp, AMC, or Biogen?

June 17, 2021

Biogen Discontinues Tau Antibody Program For Alzheimer's After Mid-Stage Study Flops

June 17, 2021

Biogen halts development of antibody drug aimed at Alzheimer’s

June 16, 2021

First Patient Set To Receive Biogen's Alzheimer's Drug: Reuters

June 16, 2021

Cramer Shares His Thoughts On Vertex Pharma, Snap And More

June 16, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Chronicle Journal: Finance

Chronicle Journal

Biogen, Inc. (NQ: BIIB )

Price and Volume

Top News

Performance

More News

Contact us

Sections

Services

Search